Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of SLIT2 mRNA | decreases expression | 20406850
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SLIT2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLIT2 mRNA | affects expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of SLIT2 mRNA | affects expression | 17331233
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLIT2 mRNA | decreases expression | 20018196 19150397 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SLIT2 mRNA | increases expression | 20106945
|
C017180 |
decamethrin |
decamethrin results in decreased expression of SLIT2 mRNA | decreases expression | 19017407
|
C014347 |
decitabine |
decitabine results in increased expression of SLIT2 mRNA | increases expression | 19100240
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of SLIT2 mRNA | decreases expression | 20713471
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SLIT2 mRNA | increases expression | 17426115
|
D012643 |
Selenium |
Selenium results in decreased expression of SLIT2 mRNA | decreases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLIT2 mRNA | decreases expression | 16443690
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.56 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.51 | 11922910 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.96 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
1.96 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.63 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.63 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| 19100240 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.08 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.08 | 12907637 12619106 21507988 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.62 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.67 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.67 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.67 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
16.67 | 16192471 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.03 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.03 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 12621046 16354765 15668235 15340226 8697196 |
MESH:D003092 |
Colitis |
|
Selenium |
3.92 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.35 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
decamethrin |
2.96 | 19861644 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.37 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.37 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.37 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 15322242 16714409 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.29 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.10 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.93 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.93 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.09 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.56 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.17 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.17 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 18606429 8697196 15340226 16959395 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.27 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.37 | 16624496 |
MESH:D007299 |
Insect Bites and Stings |
|
decamethrin |
5.97 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.40 | 8314463 18776723 10903974 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.99 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.58 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.58 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.12 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.11 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.39 | 18704418 18460780 17679729 18206229 19387464 19010910 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.64 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.99 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.99 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.99 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.99 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.70 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.70 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
14.70 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.70 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.16 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.53 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
3.53 | 1399818 16271038 15390079 21163286 17909032 20512841 7750092 20970405 10545420 11893704 16337739 6695378 9230183 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.53 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.49 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.83 | 15318939 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.26 | 17785578 16505122 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.47 | 16966607 16166281 18303189 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.47 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.42 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.44 | 19010910 19157545 16882708 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.19 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.19 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.53 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.68 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.80 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.06 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.03 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11896295 11118676 11222880 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.87 | 17616702 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.06 | 17365031 17975199 15814490 17322281 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.52 | 19155313 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.41 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.30 | 19087683 17616700 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.09 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |